BINH NGUYEN: Open Payments
NPI 1861450769 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 62 payments from 19 companies in 2025. Trend: 2023 $1,671 · 2024 $1,593 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $250 |
| Novo Nordisk Inc | 8 | $141 |
| Lilly USA, LLC | 9 | $129 |
| PFIZER INC. | 5 | $106 |
| Astellas Pharma US Inc | 4 | $78 |
| Dexcom, Inc. | 4 | $73 |
| Exact Sciences Corporation | 4 | $65 |
| Optinose US, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $36 |
Products named: AIRSUPRA, MOUNJARO, Veozah, Dexcom G6 Transmitter, ELIQUIS, Ozempic, Xhance, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
